The global lupus nephritis treatment market, which reached a valuation of US$ 1.8 billion in 2022, is anticipated to expand at a robust CAGR of 11% over the forecast period from 2023 to 2033, ultimately accumulating a projected market value of US$ 5.67 billion. The steady growth trajectory of the market is underpinned by a …